Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Genomic and genetic alterations influence the progression of gastric cancer Nobili S; Bruno L; Landini I; Napoli C; Bechi P; Tonelli F; Rubio CA; Mini E; Nesi GWorld J Gastroenterol 2011[Jan]; 17 (3): 290-9Gastric cancer is one of the leading causes of cancer-related deaths worldwide, although the incidence has gradually decreased in many Western countries. Two main gastric cancer histotypes, intestinal and diffuse, are recognised. Although most of the described genetic alterations have been observed in both types, different genetic pathways have been hypothesized. Genetic and epigenetic events, including 1q loss of heterozygosity (LOH), microsatellite instability and hypermethylation, have mostly been reported in intestinal-type gastric carcinoma and its precursor lesions, whereas 17p LOH, mutation or loss of E-cadherin are more often implicated in the development of diffuse-type gastric cancer. In this review, we summarize the sometimes contradictory findings regarding those markers which influence the progression of gastric adenocarcinoma.|*Disease Progression[MESH]|*Genome, Human[MESH]|DNA Methylation[MESH]|Epigenomics[MESH]|Genomic Instability[MESH]|Humans[MESH]|Loss of Heterozygosity[MESH]|Microsatellite Repeats[MESH]|Mutation[MESH]|Signal Transduction/genetics[MESH]|Stomach Neoplasms/*genetics/*physiopathology[MESH] |
